All News #Library
Others
Kimera® Labs Responds to FDA Warning Letter
23 Jan 2024 //
PR NEWSWIRE
Kymera Therapeutics Karen Weisbach as Vice President, Jolly Bhatia
29 Jul 2021 //
GLOBENEWSWIRE
23 Jan 2024 //
PR NEWSWIRE
29 Jul 2021 //
GLOBENEWSWIRE
Market Place
Sourcing Support